| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 297.287 | 379.067 | 313.600 | 360.139 | 357.212 | 266.158 | 435.411 | 323.246 | 907.973 | 320.998 |
| Total Income - EUR | 306.933 | 427.512 | 325.022 | 377.451 | 384.955 | 274.670 | 596.691 | 430.796 | 826.527 | 751.528 |
| Total Expenses - EUR | 232.619 | 286.179 | 285.240 | 296.661 | 306.645 | 257.180 | 267.857 | 800.099 | 818.828 | 793.475 |
| Gross Profit/Loss - EUR | 74.315 | 141.333 | 39.782 | 80.790 | 78.311 | 17.490 | 328.834 | -369.303 | 7.699 | -41.947 |
| Net Profit/Loss - EUR | 62.297 | 141.333 | 36.150 | 78.360 | 75.523 | 15.867 | 324.774 | -372.359 | 3.842 | -41.947 |
| Employees | 2 | 3 | 3 | 3 | 2 | 2 | 1 | 4 | 6 | 3 |
Check the financial reports for the company - Diagra Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 102.899 | 241.608 | 252.706 | 331.141 | 226.092 | 135.938 | 324.500 | 770.947 | 928.170 | 1.031.168 |
| Current Assets | 77.737 | 184.409 | 129.636 | 149.809 | 244.793 | 80.260 | 601.538 | 659.993 | 188.971 | 58.461 |
| Inventories | 26.366 | 45.059 | 45.788 | 59.094 | 52.409 | 66.218 | 278.850 | 618.356 | 133.971 | 248.152 |
| Receivables | 3.597 | 3.121 | 6.725 | 9.116 | 4.811 | 5.572 | 247.046 | 36.252 | 45.760 | -204.265 |
| Cash | 47.774 | 136.229 | 77.122 | 81.599 | 187.574 | 8.469 | 75.641 | 5.384 | 9.240 | 14.575 |
| Shareholders Funds | 111.119 | 142.027 | 59.063 | 136.339 | 209.222 | 37.506 | 361.449 | -9.788 | -5.916 | -47.830 |
| Social Capital | 117 | 116 | 114 | 112 | 110 | 108 | 105 | 105 | 105 | 105 |
| Debts | 69.517 | 283.991 | 323.279 | 344.611 | 261.664 | 178.692 | 576.525 | 1.450.088 | 1.130.729 | 1.145.088 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Diagra Srl